Select a community
All Communities
Home > Community Treatment Reports > Hydroxychloroquine Treatment Report
What is Hydroxychloroquine?

Hydroxychloroquine is used to prevent and treat acute attacks of malaria. It is also used to treat discoid or systemic lupus erythematosus and rheumatoid arthritis in patients whose symptoms have not improved with other treatments. Read more...Click to read more below

Side Effects

Side effects as an overall problem

Severe
0 0%
Moderate
3 20%
Mild
7 47%
None
5 33%

Most commonly reported side effects

darkening of hyperpigmentated skin spots
4 27%
Fatigue
4 27%
stomah aches
2 13%
gas
1 7%
slight hair loss
1 7%
rapid heart rate
1 7%
  • Mild
  • Moderate
  • Severe

Dosages

  2 mg daily 10 mg daily 25 mg daily 200 mg daily 300 mg daily 400 mg daily 800 mg daily
  1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 18 Number of Patients: 18 3 Number of Patients: 3 55 Number of Patients: 55 1 Number of Patients: 1  

Stop Reasons

Why Patients Stopped Taking Hydroxychloroquine (multiple reasons could be selected)
Reason # Patients Percentage of patients
Did not seem to work
4 29% Did not seem to work: 29%
Doctor's advice
4 29% Doctor's advice: 29%
Other
4 29% Other: 29%
Side effects too severe
3 21% Side effects too severe: 21%

See all 11 patients who’ve stopped taking Hydroxychloroquine

Currently Taking Hydroxychloroquine

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
2
12
12
11
21

Stopped Taking Hydroxychloroquine

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
2
3
2
2
0
2

Adherence, Burden & Cost See details from patient evaluations

Adherence

Taking treatment as prescribed

Always
11 73%
Usually
3 20%
Sometimes
1 7%
Never
0 0%

Burden

Difficulty being on treatment

Very
0 0%
Somewhat
2 13%
A little
3 20%
Not at all
10 67%

Cost

Paid out of pocket

$200+
0 0%
$100-199
0 0%
$50-99
0 0%
$25-49
2 13%
< $25
8 53%

See more information, including instructions, precautions, side effects, and interactions.

Report created on November 23, 2009.